The team used deferiprone, an iron chelator used to treat patients with a condition known as hemochromatosis, or iron ...

Iron drives inflammation in the lungs during an allergic asthma attack, presenting a target for new treatments.

New USC research shows that iron serves as a gas pedal driving certain immune cells that cause inflammation in the lungs ...

Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people ...

Jaundice, also known as icterus, is the yellowish discoloration of the skin and eyes caused by the abnormal buildup of an ...

Akebia to host conference call at 8:00 a.m. ET on May 9 Vafseo® (vadadustat) tablets FDA approved on March 27, 2024 Vafseo launch activities underway with availability expected in January 2025 ...